Emma Reeve

CIK: 0001680329

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)19 (57.6%)

Position reduction

Option Exercises (M)10 (30.3%)

Derivative conversions

Awards (A)4 (12.1%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

WHWK

Whitehawk Therapeutics, Inc.

Director

PTCT

PTC THERAPEUTICS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (33 total)

WHWK
Whitehawk Therapeutics, Inc.
Jun 12, 2026
Award(A)
Stock Option (right to buy)
Direct
38K shares-
PTCT
PTC THERAPEUTICS, INC.
Jan 5, 2026
Exercise(M)
Direct
734 shares at avg. $46.54$34K
PTCT
PTC THERAPEUTICS, INC.
Jan 5, 2026
Sale(S)
Direct
734 shares at avg. $76.00$56K
PTCT
PTC THERAPEUTICS, INC.
Jan 2, 2026
Award(A)
Direct
4K shares-
PTCT
PTC THERAPEUTICS, INC.
Dec 3, 2025
Sale(S)
Direct
733 shares at avg. $78.62$58K
PTCT
PTC THERAPEUTICS, INC.
Dec 3, 2025
Exercise(M)
Direct
733 shares at avg. $46.54$34K
PTCT
PTC THERAPEUTICS, INC.
Nov 21, 2025
Sale(S)
Direct
10K shares at avg. $79.50$795K
PTCT
PTC THERAPEUTICS, INC.
Nov 21, 2025
Exercise(M)
Direct
10K shares at avg. $51.16$512K
PTCT
PTC THERAPEUTICS, INC.
Nov 12, 2025
Sale(S)
Direct
7.3K shares at avg. $74.50$546K
PTCT
PTC THERAPEUTICS, INC.
Nov 12, 2025
Exercise(M)
Direct
7.3K shares at avg. $46.54$341K
PTCT
PTC THERAPEUTICS, INC.
Oct 30, 2025
Exercise(M)
Direct
12K shares at avg. $38.10$457K
PTCT
PTC THERAPEUTICS, INC.
Oct 30, 2025
Sale(S)
Direct
12K shares at avg. $69.50$834K
PTCT
PTC THERAPEUTICS, INC.
Oct 30, 2025
Sale(S)
Direct
3.7K shares at avg. $69.50$255K
PTCT
PTC THERAPEUTICS, INC.
Oct 3, 2025
Exercise(M)
Direct
10K shares at avg. $39.42$394K
PTCT
PTC THERAPEUTICS, INC.
Oct 3, 2025
Sale(S)
Direct
4.6K shares at avg. $66.09$303K
PTCT
PTC THERAPEUTICS, INC.
Oct 3, 2025
Sale(S)
Direct
2.4K shares at avg. $66.87$159K
PTCT
PTC THERAPEUTICS, INC.
Oct 3, 2025
Exercise(M)
Direct
6.9K shares at avg. $33.02$228K
PTCT
PTC THERAPEUTICS, INC.
Oct 3, 2025
Sale(S)
Direct
2.2K shares at avg. $65.02$141K
PTCT
PTC THERAPEUTICS, INC.
Oct 3, 2025
Sale(S)
Direct
3.1K shares at avg. $66.11$208K
PTCT
PTC THERAPEUTICS, INC.
Oct 3, 2025
Sale(S)
Direct
1.6K shares at avg. $66.93$107K
PTCT
PTC THERAPEUTICS, INC.
Oct 3, 2025
Exercise(M)
Direct
8.7K shares at avg. $33.63$291K
PTCT
PTC THERAPEUTICS, INC.
Oct 3, 2025
Sale(S)
Direct
2.7K shares at avg. $65.05$178K
PTCT
PTC THERAPEUTICS, INC.
Oct 3, 2025
Sale(S)
Direct
4K shares at avg. $66.10$267K
PTCT
PTC THERAPEUTICS, INC.
Oct 3, 2025
Sale(S)
Direct
1.9K shares at avg. $66.89$126K
PTCT
PTC THERAPEUTICS, INC.
Oct 3, 2025
Sale(S)
Direct
3K shares at avg. $65.09$197K

		Type	Shares	Price		Ownership
Jun 12, 2026	WHWK Whitehawk Therapeutics, Inc.	Award(A) Stock Option (right to buy)	38,040	-	-	Direct
Jan 5, 2026	PTCT PTC THERAPEUTICS, INC.	Exercise(M)	734	$46.54	$34,160	Direct
Jan 5, 2026	PTCT PTC THERAPEUTICS, INC.	Sale(S)	734	$76.00	$55,784	Direct
Jan 2, 2026	PTCT PTC THERAPEUTICS, INC.	Award(A)	4,000	-	$0	Direct
Dec 3, 2025	PTCT PTC THERAPEUTICS, INC.	Sale(S)	733	$78.62	$57,628	Direct
Dec 3, 2025	PTCT PTC THERAPEUTICS, INC.	Exercise(M)	733	$46.54	$34,114	Direct
Nov 21, 2025	PTCT PTC THERAPEUTICS, INC.	Sale(S)	10,000	$79.50	$795,000	Direct
Nov 21, 2025	PTCT PTC THERAPEUTICS, INC.	Exercise(M)	10,000	$51.16	$511,600	Direct
Nov 12, 2025	PTCT PTC THERAPEUTICS, INC.	Sale(S)	7,333	$74.50	$546,309	Direct
Nov 12, 2025	PTCT PTC THERAPEUTICS, INC.	Exercise(M)	7,333	$46.54	$341,278	Direct
Oct 30, 2025	PTCT PTC THERAPEUTICS, INC.	Exercise(M)	12,000	$38.10	$457,200	Direct
Oct 30, 2025	PTCT PTC THERAPEUTICS, INC.	Sale(S)	12,000	$69.50	$834,000	Direct
Oct 30, 2025	PTCT PTC THERAPEUTICS, INC.	Sale(S)	3,666	$69.50	$254,787	Direct
Oct 3, 2025	PTCT PTC THERAPEUTICS, INC.	Exercise(M)	10,000	$39.42	$394,200	Direct
Oct 3, 2025	PTCT PTC THERAPEUTICS, INC.	Sale(S)	4,591	$66.09	$303,419	Direct
Oct 3, 2025	PTCT PTC THERAPEUTICS, INC.	Sale(S)	2,381	$66.87	$159,217	Direct
Oct 3, 2025	PTCT PTC THERAPEUTICS, INC.	Exercise(M)	6,912	$33.02	$228,234	Direct
Oct 3, 2025	PTCT PTC THERAPEUTICS, INC.	Sale(S)	2,163	$65.02	$140,638	Direct
Oct 3, 2025	PTCT PTC THERAPEUTICS, INC.	Sale(S)	3,149	$66.11	$208,180	Direct
Oct 3, 2025	PTCT PTC THERAPEUTICS, INC.	Sale(S)	1,600	$66.93	$107,088	Direct
Oct 3, 2025	PTCT PTC THERAPEUTICS, INC.	Exercise(M)	8,650	$33.63	$290,900	Direct
Oct 3, 2025	PTCT PTC THERAPEUTICS, INC.	Sale(S)	2,729	$65.05	$177,521	Direct
Oct 3, 2025	PTCT PTC THERAPEUTICS, INC.	Sale(S)	4,037	$66.10	$266,846	Direct
Oct 3, 2025	PTCT PTC THERAPEUTICS, INC.	Sale(S)	1,884	$66.89	$126,021	Direct
Oct 3, 2025	PTCT PTC THERAPEUTICS, INC.	Sale(S)	3,028	$65.09	$197,093	Direct

1-25 of 33 transactions

About Reeve Emma

Reeve Emma (SEC CIK 0001680329) files insider reports with the SEC as Director of Whitehawk Therapeutics, Inc. (WHWK) and Director of PTC THERAPEUTICS, INC. (PTCT).

Signal8 holds 10 ownership filings by Reeve Emma, all Form 4s, filed between Jan 7, 2025 and Jun 15, 2026. Those filings report 33 transactions, from Jan 3, 2025 to Jun 12, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Reeve Emma's filings is in MORRISTOWN, NJ.

Recent filings by Reeve Emma

Jun 12, 2026: Grant or award of WHWK derivative securities (Form 4, code A).
Jan 5, 2026: Option exercise of PTCT shares (Form 4, code M).
Jan 5, 2026: Open-market sale of PTCT shares (Form 4, code S).
Jan 2, 2026: Grant or award of PTCT shares (Form 4, code A).
Dec 3, 2025: Open-market sale of PTCT shares (Form 4, code S).

Other insiders filing for Whitehawk Therapeutics, Inc. (WHWK)

Giacobello Scott M., CHIEF FINANCIAL OFFICER
BALL BRYAN
Dornan David, Chief Scientific Officer
Lennon David James, CHIEF EXECUTIVE OFFICER
Dugan Margaret, Chief Medical Officer
Iyengar Vijay K, Director

How to read Form 4 transaction codes